| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1073463A4 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 01/09/2002 | EP0873354A4 Novel amp activated protein kinase |
| 01/09/2002 | EP0811164B1 Early detection of prostate cancer (cap) by determining a ratio involving prostate specific antigen (psa) and human glandular kallikrein (hgk-1) concentrations |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | CN1330665A Multiple domain glycoprotein hormones and methods of using |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330662A Heliobacter pylori antigen |
| 01/09/2002 | CN1330555A Antibodies to truncated VEGF-D and uses thereof |
| 01/09/2002 | CN1330554A Chimeric anti-CD20 antibody treatment of paitients receiving BMT or PBSC transplants |
| 01/09/2002 | CN1330146A Polypeptide-human dynein receptor-similar kinase 43 and polynucleotide for coding it |
| 01/09/2002 | CN1330081A Single-chain antibody resisting HIV-1 outer membrane protein and recombinant immunotoxin |
| 01/09/2002 | CN1330079A Polypeptide-RNA polymerase II associated protein 9.57 and polynucleotide for encoding it |
| 01/09/2002 | CN1330078A Polypeptide-negative regulatory factor 9.02 of protein activating GTP enzyme and polynucleotide for coding it |
| 01/09/2002 | CN1329922A Join of C peptide and insulin for treating diabetes complication and C peptide-specific antibody |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/08/2002 | US6337391 Polycation-sensing receptor in aquatic species and methods of use |
| 01/08/2002 | US6337386 Toxin Assay |
| 01/08/2002 | US6337207 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 01/08/2002 | US6337074 Antiviral agent capable of disrupting the association of two viral proteins required for dna replication in herpesviruses |
| 01/08/2002 | US6337070 Polypeptides for use in generating anti-human influenza virus antibodies |
| 01/08/2002 | CA2116560C Morphogenic protein screening method |
| 01/08/2002 | CA2021594C Antibody to human interleukin-6 receptor |
| 01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
| 01/03/2002 | WO2002000924A2 Viral phospholipase a2 enzymes, anti-viral agents and methods of use |
| 01/03/2002 | WO2002000914A2 Bioengineered vehicles for targeted nucleic acid delivery |
| 01/03/2002 | WO2002000882A2 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 01/03/2002 | WO2002000860A2 Novel proteases |
| 01/03/2002 | WO2002000840A2 Human lyases |
| 01/03/2002 | WO2002000729A2 Generation of libraries of antibodies in yeast and uses thereof |
| 01/03/2002 | WO2002000728A2 Methods and compositions for isolating biologically active antibodies |
| 01/03/2002 | WO2002000727A2 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | WO2002000725A2 G-protein coupled receptor org10 |
| 01/03/2002 | WO2002000724A2 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | WO2002000721A2 Cytokine receptor zcytor17 |
| 01/03/2002 | WO2002000715A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | WO2002000711A2 Ev-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | WO2002000710A2 B7-like molecules and uses thereof |
| 01/03/2002 | WO2002000695A2 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | WO2002000690A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | WO2002000685A1 Localized delivery to a target surface |
| 01/03/2002 | WO2002000245A1 Neurotoxic oligomers |
| 01/03/2002 | WO2002000174A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/03/2002 | WO2002000005A1 Libraries displaying human antibody fragments with hybrid complementarity determining regions |
| 01/03/2002 | WO2001075097A3 Improvements to ribosome display |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001068134A3 Therapies that improve graft survival, using antibodies against a b7 antigen |
| 01/03/2002 | WO2001066063A3 Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis |
| 01/03/2002 | WO2001055336A3 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
| 01/03/2002 | WO2001049713A3 Stabilizing peptides, polypeptides and antibodies which include them |
| 01/03/2002 | WO2001046696A3 Methods and compositions for detecting hepatitis e virus |
| 01/03/2002 | WO2001032877A3 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 01/03/2002 | WO2000061171A9 Uses of mammalian ox2 protein and related reagents |
| 01/03/2002 | US20020002273 Rapamycin assay |
| 01/03/2002 | US20020002271 Separating immunoglobulin from mixture; load sample onto chromatographic apparatus, elute immunoglobulin |
| 01/03/2002 | US20020002270 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 01/03/2002 | US20020002269 Artemin, a neurotrophic factor |
| 01/03/2002 | US20020002132 Use of interleukin-4 antagonists and compositions thereof |
| 01/03/2002 | US20020001857 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 01/03/2002 | US20020001824 Ligand-gated anion channels of insects |
| 01/03/2002 | US20020001817 Assay for specific strains of multiple disease related conformations of a protein |
| 01/03/2002 | US20020001798 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 01/03/2002 | US20020001588 Coupling drugs to an antibody (polyclonal) or fragment or derivative that recognizes a substance (antigen) unique to an organ; antitumor agents for treatment of adenocarcinoma, benign prostatic hypertrophy, and prostatitis |
| 01/03/2002 | US20020001586 Inhibiting proliferation of neural cells via contacting with antibody, antisense nucleotide, and/or polynucleotide that disrupts activity of granulin molecule |
| 01/03/2002 | US20020001585 Administering a blocking agent of tumor necrosis factors or receptors; treatment of Sin Nombre (SNV), Ebola, Marburg, Lassa, and Dengue viral disease |
| 01/03/2002 | DE10029705A1 Preparing egg yolk antibodies without Fc region, useful therapeutically and for immunoassays, comprises immunization then recovery on carrier matrix under selected conditions |
| 01/03/2002 | CA2709771A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648051A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648048A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648046A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2417699A1 Helicobacter pylori heptosyl transferase polypeptides |
| 01/03/2002 | CA2415238A1 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 01/03/2002 | CA2414308A1 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 01/03/2002 | CA2413747A1 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | CA2413673A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/03/2002 | CA2413354A1 Neurotoxic a.beta. oligomers in alzheimer's disease |
| 01/03/2002 | CA2412635A1 Novel proteases |
| 01/03/2002 | CA2412612A1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | CA2412610A1 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2412239A1 Cytokine receptor zcytor17 |
| 01/03/2002 | CA2412211A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2411515A1 Generation of libraries of antibodies in yeast and uses thereof |
| 01/03/2002 | CA2381338A1 Human lyases |
| 01/02/2002 | EP1167537A1 Process for producing monoclonal antibody |
| 01/02/2002 | EP1167389A1 Antibodies against the protein SEMP1, methods for their production and uses thereof |
| 01/02/2002 | EP1167388A1 Single-stranded fv inducing apoptosis |
| 01/02/2002 | EP1167387A1 Antibodies against SEMP1, methods for their production and uses thereof |
| 01/02/2002 | EP1167386A1 Canine and feline melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 01/02/2002 | EP1167384A1 HVEGF Receptor as Vascular endothelial cell growth factor antagonists |
| 01/02/2002 | EP1166121A1 Selection of intracellular immunoglobulins |
| 01/02/2002 | EP1166112A1 Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same |
| 01/02/2002 | EP1165828A1 50 human secreted proteins |
| 01/02/2002 | EP1165827A1 45 human secreted proteins |
| 01/02/2002 | EP1165805A1 Dsp-2 dual-specificity map kinase phosphatase |
| 01/02/2002 | EP1165795A2 Streptococcus pneumoniae antigens |
| 01/02/2002 | EP1165789A2 Vesicle associated proteins |